Design, Synthesis, and Anti-Glioma Activity Evaluation of Dehydroabietic Acid Derivatives

IF 1.9 4区化学 Q3 CHEMISTRY, MULTIDISCIPLINARY

ChemistrySelect Pub Date : 2025-02-03 DOI:10.1002/slct.202404226

Yuanhui Liu, Yifeng Qiu, Ming Li, Ying Liu, Yan Luo, Gong Chen, Lianbao Ye

{"title":"Design, Synthesis, and Anti-Glioma Activity Evaluation of Dehydroabietic Acid Derivatives","authors":"Yuanhui Liu, Yifeng Qiu, Ming Li, Ying Liu, Yan Luo, Gong Chen, Lianbao Ye","doi":"10.1002/slct.202404226","DOIUrl":null,"url":null,"abstract":"Dehydroabietic acid (DHAA) is a common natural product with a broad range of biological activities. In previous research, our group identified a range of dehydroabietic acid derivatives with strong anti-glioma activity. In order to search for better anti-glioma drugs candidates, new chalcone derivatives A1-A10 and B1-B10 were designed and synthesized in this study. The antiproliferative activity of these derivatives against U87 glioma cells was tested by CCK-8 assay, in which A10 has the best IC50 value of 11.39 µM. Scratch and cloning studies further confirmed that A10 strongly inhibited the proliferation and colony-forming activity of U87 cells. The antiproliferative activity of A10 on U87 cells showed some concentration dependence manner and the pKa values of A10 were within the desirable range of anti-gliomas drugs. In addition, molecular docking revealed hydrogen bonding interaction was formed between A10 and the target protein. These results suggest that A10 may be a promising DHAA-derived lead compound that deserves further strategic optimization in search of the anticancer candidates against glioma.","PeriodicalId":146,"journal":{"name":"ChemistrySelect","volume":"10 5","pages":""},"PeriodicalIF":1.9000,"publicationDate":"2025-02-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ChemistrySelect","FirstCategoryId":"92","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/slct.202404226","RegionNum":4,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CHEMISTRY, MULTIDISCIPLINARY","Score":null,"Total":0}

引用次数: 0

Abstract

Dehydroabietic acid (DHAA) is a common natural product with a broad range of biological activities. In previous research, our group identified a range of dehydroabietic acid derivatives with strong anti-glioma activity. In order to search for better anti-glioma drugs candidates, new chalcone derivatives A1-A10 and B1-B10 were designed and synthesized in this study. The antiproliferative activity of these derivatives against U87 glioma cells was tested by CCK-8 assay, in which A10 has the best IC₅₀ value of 11.39 µM. Scratch and cloning studies further confirmed that A10 strongly inhibited the proliferation and colony-forming activity of U87 cells. The antiproliferative activity of A10 on U87 cells showed some concentration dependence manner and the pKa values of A10 were within the desirable range of anti-gliomas drugs. In addition, molecular docking revealed hydrogen bonding interaction was formed between A10 and the target protein. These results suggest that A10 may be a promising DHAA-derived lead compound that deserves further strategic optimization in search of the anticancer candidates against glioma.

Abstract Image

查看原文本刊更多论文

求助全文

约1分钟内获得全文求助全文

来源期刊

ChemistrySelect Chemistry-General Chemistry

CiteScore

3.30

自引率

4.80%

发文量

1809

审稿时长

1.6 months

期刊介绍： ChemistrySelect is the latest journal from ChemPubSoc Europe and Wiley-VCH. It offers researchers a quality society-owned journal in which to publish their work in all areas of chemistry. Manuscripts are evaluated by active researchers to ensure they add meaningfully to the scientific literature, and those accepted are processed quickly to ensure rapid online publication.